Co-Authors
This is a "connection" page, showing publications co-authored by Ennio Favalli and Carlo Selmi.
Connection Strength
0.383
-
Comments on "Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective study". J Am Acad Dermatol. 2018 12; 79(6):e119-e120.
Score: 0.195
-
How advances in personalized medicine will change rheumatology. Per Med. 2018 03; 15(2):75-78.
Score: 0.188